In episode 10 of Examining the Psychedelic Renaissance, a panel of doctors and experts will discuss the use of MDMA-assisted therapy to treat eating disorders and PTSD.
Date: Tuesday, November 24th
Time: 5:00 PM – 6:30 PM PST (8:00 PM – 9:30 PM EST)
Dr. Adele Lafrance
Dr. Lafrance is the co-creator of the Emotion-Focused Family Therapy treatment model (EFFT), which focuses on at-home support for patients with eating disorders. She also developed a comprehensive manual on emotional health, which is recognized by the American Psychological Association.
Dr. Lafrance’s approach to care has revolutionized our understanding of the tools needed to treat eating disorders, by teaching parents and loved ones to become primary caregivers. The model for EFFT focuses on teaching these primary caregivers to deliver emotional support using two key tools; validation of a patient’s feelings and providing support in times of crisis.
Dr. Lafrance’s EFFT, as well as her work with Cedar Psychiatry alongside fellow panelist Dr. Reid Robinson, has made her a leader in the advancement of studying MDMA, psilocybin, ketamine and ayahuasca to cure treatment resistant eating disorders. Work which has ultimately brought her to our panel today.
You can learn more about EFFT here.
About Dr. Reid Robinson
Dr. Robinson has co-founded several institutes and clinics to combat mental illness and promote psychedelic medicine. A man of many hats, he founded Polizzi Clinic and serves as medical director at both Center for Change and Cedar Psychiatry.
Dr. Robinson is also the coordinating investigator of MAPS’ MDMA study of Eating Disorders, where he supervises training and compiles research from participating clinics and therapy sites.
Dr. Robinson also co-founded three startups to advance innovative and ground-breaking clinical trials. including Clinical Methods, Anolix and Tute Genomics – where he served as CEO.
You can read more about Dr. Robinson here.
About Dr. Anne Wagner
Dr. Wagner is the founder and lead psychologist at Remedy, a center offering individual, family and group therapy. Remedy also serves as a training clinic specializing in trauma care, as well as being a prominent figure in the clinical research of MDMA.
Dr. Wagner holds an Adjunct Professorship and residency at Ryerson University, where she obtained her PH.D in Clinical Psychology. She also holds a seat on the Quality Committee of Casey House, an HIV/AIDS hospital in Toronto.
Currently her focus is at Remedy, on a MAPS funded MDMA assisted Cognitive Processing Therapy clinical trial, where her knowledge of good practice, law and ethics has helped push the trial forward.
You can read more about Dr. Wagner here.
Examining the Psychedelic Renaissance – Season 2 has three different price points , starting from $75.00 for the full 15 episodes. Single episodes are available for $15 each, with discounted rates for students, seniors and those affected by COVID-19. If cost is a barrier for your participation, please email email@example.com for a complimentary ticket. Tickets can be purchased online at www.mapscanada.org/webinar